This research suggests that EA intervention attenuates hyperandrogenemia, insulin resistance, mitochondrial dysfunction and oxidative stress in PCOS-like model via inhibiting the expression of lipid metabolism regulator SREBP1. The gene discussed is SREBF1; the disease is polycystic ovary syndrome.